Navigation Links
Stem Cell Breakthrough Could End Human Embryonic Experimentation
Date:11/21/2007

Cloner of 'Dolly the Sheep' denounces life-destructive research in light of

new discovery

MADISON, Wis., Nov. 21 /PRNewswire/ -- Researchers have announced this week that they have made a significant breakthrough in stem cell research using adult skin cells that could end the use of live human embryos as research subjects.

Scientists from the University of Wisconsin at Madison announced that they have identified four genes that, when manipulated, can force a skin cell back to the embryonic stage, creating a potentially unlimited supply of stem cells without having to destroy human embryonic life. The discovery was made simultaneously with independent researchers in Japan.

In the wake of this discovery, the famed cloner of "Dolly the Sheep," Prof. Ian Wilmut, has abandoned and denounced the life-destructive therapeutic cloning in favor of the more ethical production of human stem cells through the use of adult skin cells, signaling the possible end to academic acceptance of live human embryonic experimentation.

"Once and for all, we urge the scientific and medical communities to embrace the life-affirming research done on cells that do not cause the intentional destruction of innocent human life at the earliest, most vulnerable stages of development," said Operation Rescue President Troy Newman. "There is no way to justify continued destructive research, which has yielded no cures of any kind."

Operation Rescue was one of the first groups in the nation to begin speaking out against live human embryonic experimentation when it launched protests against human experimentation labs in 1999.

Embryonic stem cells are prized by researchers for their ability to grow into any type of tissue in the body without degenerating, but with tragic side effects, such as massive tumor growth and other fatal complications. These complications have prevented stem cells derived by killing human embryos from making even one substantial breakthrough that has helped suffering patients.

On the other hand, research done on adult cells that do not require the taking of life has produced hundreds of breakthroughs that are helping people today.

Contact:

Troy Newman, President Operation Rescue: 316-842-1700

Cheryl Sullenger, Senior Policy Advisor, Operation Rescue: 316-516-3034


'/>"/>
SOURCE Operation Rescue
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test
3. Kingfisher Healthcare Launches Breakthrough Product in Europe
4. New technique can be breakthrough for early cancer diagnosis
5. Breakthrough research identifies how cells from pigs may cure diabetes
6. Harmonex Introduces CliniCom(TM), a Breakthrough in Psychiatric Intake and Assessment Technology
7. Medical Breakthrough ... Doctor Discovers Penetrating Carrier That Eradicates Fungus
8. H&V Introduces HVision Technology Platform to Accelerate Development of Breakthrough Products
9. Discovery Institute Bioethicist Lauds Breakthrough in Stem Cells Research that Eliminates Need for Human Cloning
10. The next generation: nanomagnets could replace semiconductors
11. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance ... consulting, provides a free webinar on Performing Quality Investigations: Getting to ... 12pm CT at no charge. , Incomplete investigations are still a major concern ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):